DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and is also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands could be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics. Research Beam Model: Research Beam Product ID: 20915 5370 USD New
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
 

DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023

DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personali

Category : Diagnostic and Biotech
Published On : May  2017
Pages : 160

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and is also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands could be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Technological advancements in sequencing equipment, surge in applications of DNA sequencing, and increase in genome mapping programs drive the global DNA sequencing market. In addition, rise in awareness pertaining to DNA sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to DNA sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and the untapped emerging countries offer lucrative opportunities for the market players.

The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is categorized into consumable, instrument, and service. The consumables segment occupied dominant share in 2016, and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of DNA sequencing.

Based on application, it is bifurcated into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2016, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D globally and surge in awareness about DNA sequencing applications in precision medicine. Based on technology, the DNA sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing technologies. The sequencing by synthesis technology segment accounted for the highest share in 2016, and is estimated to continue this trend throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing, structural variation detection, sequence assembly, and others.

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the DNA sequencing market in 2016, and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of DNA sequencing. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize DNA sequencing in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global DNA sequencing market.

KEY PLAYERS PROFILED

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG
  • Pacific Biosciences of California, Inc.
  • ZS Genetics, Inc.
  • Beckman Coulter (Fullerton, CA)
  • 454 Life Sciences Corporation (Roche Holding AG)
  • Agilent Technologies, Inc.
  • Abbott Laboratories.
  • LI-COR, Inc.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global DNA sequencing market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry

KEY MARKET SEGMENTS

By Product

  • Consumable
  • Instrument
  • Service

By Application

  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real-Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By End User    

  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics    

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

The other players in the value chain include (profiles not included in the report)

  • Eurofins Scientific
  • Gatc Biotech AG
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • Biomatters Ltd.
  • New England Biolabs, Inc.
  • Myriad Genetics, Inc.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS

3.5.1. DNA sequencing market share (2012-2017)

3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL DNA SEQUENCING MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. CONSUMABLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast

4.3. INSTRUMENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. SERVICES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

CHAPTER 5 GLOBAL DNA SEQUENCING MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. BIOMARKERS AND CANCER

5.2.1. Market size & forecast

5.3. DIAGNOSTICS

5.3.1. Market size & forecast

5.4. REPRODUCTIVE HEALTH

5.4.1. Market size & forecast

5.5. PERSONALIZED MEDICINE

5.5.1. Market size & forecast

5.6. FORENSICS

5.6.1. Market size & forecast

5.7. OTHER APPLICATIONS

5.7.1. Market size & forecast

CHAPTER 6 GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. SEQUENCING BY SYNTHESIS (SBS)

6.2.1. Market size & forecast

6.3. ION SEMICONDUCTOR SEQUENCING (IOS)

6.3.1. Market size & forecast

6.4. SEQUENCING BY LIGATION (SBL)

6.4.1. Market size & forecast

6.5. PYROSEQUENCING

6.5.1. Market size & forecast

6.6. SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)

6.6.1. Market size & forecast

6.7. CHAIN TERMINATION SEQUENCING

6.7.1. Market size & forecast

6.8. NANOPORE SEQUENCING

6.8.1. Market size & forecast

CHAPTER 7 GLOBAL DNA SEQUENCING MARKET, BY END USERS

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

7.2.1. Market size & forecast

7.3. PHARMACEUTICAL COMPANIES

7.3.1. Market size & forecast

7.4. BIOTECHNOLOGY COMPANIES

7.4.1. Market size & forecast

7.5. HOSPITALS & CLINICS

7.5.1. Market size & forecast

CHAPTER 8 GLOBAL DNA SEQUENCING MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size & forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. ILLUMINA, INC

9.1.1. Operating business segments
9.1.2. Business performance

9.2. THERMO FISHER SCIENTIFIC, INC

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. SIEMENS AG

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. ZS GENETICS, INC

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. AGILENT TECHNOLOGIES, INC

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. ABBOTT LABORATORIES

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. BECKMAN COULTER

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. LI-COR

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL DNA SEQUENCING CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL DNA SEQUENCING INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL DNA SEQUENCING SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 6. BIOMARKERS AND CANCER DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. DIAGNOSTICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. REPRODUCTIVE HEALTH DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. PERSONALISED MEDICINE NEXT GENERATION SEQUENCING, BY REGION, 2016-2023 ($MILLION)
TABLE 10. FORENSICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. OTHER APPLICATIONS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 13. SEQUENCING BY SYNTHESIS TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. ION SEMICONDUCTOR SEQUENCING TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. SEQUENCING BY LIGATION TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. PYROSEQUENCING TECHNOLOGY DNA SEQUENCING MARKET TECHNOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 17. SINGLE-MOLECULE-REAL-TIME-SEQUENCING TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. CHAIN TERMINATION DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. NANOPORE DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL DNA SEQUENCING MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 21. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. PHARMACEUTICAL COMPANIES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. BIOTECHNOLOGY COMPANIES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. HOSPITALS & CLINICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. GLOBAL DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. EUROPE DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 32. EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 33. EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 35. EUROPE DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39. ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 40. ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. LAMEA DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 45. LAMEA DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 46. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 47. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 48. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT
TABLE 49. SIEMENS AG.: COMPANY SNAPSHOT
TABLE 50. ZS GENETICS, INC.: COMPANY SNAPSHOT
TABLE 51. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 52. AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT
TABLE 53. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 54. BECKMAN COULTER: COMPANY SNAPSHOT
TABLE 55. LI-COR: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 2. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 4. PATENT ANALYSIS BY REGION
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS
FIGURE 11. DNA SEQUENCINGMARKET: PRODUCT SEGMENATION
FIGURE 12. U.S. DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 13. CANADA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 15. GERMANY DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 17. UK DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 18. ITALY DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 19. SPAIN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF EUROPE DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 23. AUSTRALIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH KOREA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 26. TAIWAN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 28. BRAZIL DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY DNA SEQUENCING MARKET, 2016-20223 ($MILLION)
FIGURE 30. SAUDI ARABIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 32. ILLUMINA, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. ILLUMINA, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 34. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 36. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 37. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 39. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 40. SIEMENS AG.: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. SIEMENS AG.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 42. SIEMENS AG.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. ZS GENETICS, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. ZS GENETICS, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 45. ZS GENETICS, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 46. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): NET SALES, 2014-2017 ($MILLION)
FIGURE 47. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY SEGMENT, 2015 (%)
FIGURE 48. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 49. AGILENT TECHNOLOGIES, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. AGILENT TECHNOLOGIES, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 51. AGILENT TECHNOLOGIES, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 52. ABBOTT LABORATORIES: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. ABBOTT LABORATORIES: REVENUE BY SEGMENT, 2015 (%)
FIGURE 54. ABBOTT LABORATORIES: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 55. BECKMAN COULTER: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. BECKMAN COULTER: REVENUE BY SEGMENT, 2015 (%)
FIGURE 57. BECKMAN COULTER: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 58. LI-COR: NET SALES, 2014-2017 ($MILLION)
FIGURE 59. LI-COR: REVENUE BY SEGMENT, 2015 (%)
FIGURE 60. LI-COR: REVENUE BY GEOGRAPHY, 2015 (%)

Enquiry Before Buy